Yan Ling Tsay
About Yan Ling Tsay
Yan Ling Tsay is the Clinical Data Reporting Lead at Bristol-Myers Squibb in New Jersey, United States, with over 30 years of experience in clinical data management and biostatistics.
Company
Yan Ling Tsay currently works at Bristol-Myers Squibb, a major pharmaceutical company headquartered in New Jersey, United States. She has been employed with the company since 1993, advancing through multiple roles within the biostatistics and data management departments.
Title
Yan Ling Tsay presently holds the position of Clinical Data Reporting Lead, Clinical Data Reporting and Analytics at Bristol-Myers Squibb. In this role, she oversees the reporting and analytics of clinical data, ensuring accuracy and compliance with industry standards.
Education and Expertise
Yan Ling Tsay earned a Master's degree in Statistics from Iowa State University. Her expertise includes over 30 years of experience in clinical data management and biostatistics. Tsay is proficient in SAS programming for clinical data analysis and specializes in the QA review and documentation of clinical data/output submission files. She is also experienced in developing analysis TLF presentation plans for clinical data reporting.
Background
Yan Ling Tsay started her career at Bristol-Myers Squibb in 1993 as an Associate Manager in Data Management. Over the years, she moved through roles such as Principal Analyst I in Biostatistics and Data Management (1999-2011), Principal Analyst II in Biostatistics and Programming (2011-2019), before taking on her current role. Throughout her tenure, she has demonstrated a consistent record of managing and analyzing clinical data efficiently.
Specialization in Clinical Data Reporting
Yan Ling Tsay specializes in preparing and organizing clinical data files, ensuring they meet regulatory requirements. Her skills encompass QA review, documentation, and the development of analysis TLF presentation plans. Her extensive experience in these areas contributes significantly to the reliability and integrity of clinical data reporting at Bristol-Myers Squibb.